BDBM324423 US10189835, Compound 699
SMILES: Clc1cccc(NC(=O)N2CCc3[nH]nc(C(=O)N4CCCO4)c3C2)c1
InChI Key: InChIKey=CKAITRSZSZIZQT-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Capsid protein (Hepatitis B virus genotype C subtype ayr (isolate ...) | BDBM324423 (US10189835, Compound 699) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
NOVIRA THERAPEUTICS, INC. US Patent | Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int... | US Patent US10189835 (2019) BindingDB Entry DOI: 10.7270/Q2KP8482 | |||||||||||
More data for this Ligand-Target Pair |